Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SHERIF G EL BAYADI

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1730127168
CMS profile
168801
Location
SYRACUSE, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$115,546.68

302 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 5 of 7; records 201–250 of 302 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SHERIF G EL BAYADI

NPI 1730127168 · CMS profile ID 168801

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

SYRACUSE, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 7; records 201–250 of 302 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1730127168?year=2019&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SHERIF G EL BAYADI, NPI 1730127168, CMS profile ID 168801. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 7; records 201–250 of 302 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1730127168?year=2019&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). SHERIF G EL BAYADI, NPI 1730127168, CMS profile ID 168801. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 7; records 201–250 of 302 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1730127168?year=2019&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
SHERIF G EL BAYADI, NPI 1730127168, CMS profile ID 168801, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 7; records 201–250 of 302 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1730127168?year=2019&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

302 matching records · $115,546.68 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 302 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 302.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Teva Pharmaceuticals USA, Inc. $0.7405/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697710407 CMS
Teva Pharmaceuticals USA, Inc. $10.6005/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697832391 CMS
GlaxoSmithKline, LLC. $12.6005/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670879619 CMS
Actelion Pharmaceuticals US, Inc. $12.6305/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659741425 CMS
Actelion Pharmaceuticals US, Inc. $1,750.0005/21/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659741427 CMS
Actelion Pharmaceuticals US, Inc. $15.4505/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659741423 CMS
Mallinckrodt Enterprises LLC $4,200.0005/20/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704802197 CMS
Mallinckrodt Enterprises LLC $5,250.0005/20/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704802199 CMS
Mallinckrodt Enterprises LLC $125.0005/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704802193 CMS
Mallinckrodt Enterprises LLC $761.8705/16/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704802195 CMS
Genentech USA, Inc. $16.9605/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681303377 CMS
Mallinckrodt Enterprises LLC $89.5405/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704802189 CMS
Mallinckrodt Enterprises LLC $927.5005/14/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704802191 CMS
Regeneron Healthcare Solutions, Inc. $27.5405/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373859 CMS
Regeneron Healthcare Solutions, Inc. $24.0505/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373861 CMS
Regeneron Healthcare Solutions, Inc. $151.4805/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373863 CMS
Regeneron Healthcare Solutions, Inc. $361.9205/13/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373865 CMS
Regeneron Healthcare Solutions, Inc. $17.1005/13/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373867 CMS
GlaxoSmithKline, LLC. $426.3105/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670373623 CMS
GlaxoSmithKline, LLC. $19.6605/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670376467 CMS
Insmed, Inc. $15.4905/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693330715 CMS
Insmed, Inc. $3.2705/09/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693334459 CMS
Insmed, Inc. $0.9405/09/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693334461 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $11.1905/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700372483 CMS
GlaxoSmithKline, LLC. $4.5505/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671305287 CMS
GlaxoSmithKline, LLC. $16.7205/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670373323 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.3505/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700372485 CMS
Genentech USA, Inc. $115.7305/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681325947 CMS
Regeneron Healthcare Solutions, Inc. $11.2204/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373857 CMS
Grifols USA, LLC $11.8504/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 692586973 CMS
AstraZeneca Pharmaceuticals LP $12.4404/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685281947 CMS
GlaxoSmithKline, LLC. $15.8904/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671388623 CMS
Regeneron Healthcare Solutions, Inc. $4,430.0004/22/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373855 CMS
Teva Pharmaceuticals USA, Inc. $11.1304/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697754965 CMS
Actelion Pharmaceuticals US, Inc. $1.7804/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659741419 CMS
Actelion Pharmaceuticals US, Inc. $20.7704/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659741421 CMS
Bayer HealthCare Pharmaceuticals Inc. $18.4604/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 628444159 CMS
United Therapeutics Corporation $752.4404/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703098283 CMS
United Therapeutics Corporation $764.0004/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703098285 CMS
United Therapeutics Corporation $25.0004/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703098287 CMS
United Therapeutics Corporation $5,300.0004/12/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703098289 CMS
United Therapeutics Corporation $249.6204/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703098291 CMS
United Therapeutics Corporation $264.5904/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703098293 CMS
United Therapeutics Corporation $232.1004/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703098281 CMS
AstraZeneca Pharmaceuticals LP $66.7004/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685223363 CMS
Regeneron Healthcare Solutions, Inc. $133.6604/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373845 CMS
Regeneron Healthcare Solutions, Inc. $57.1404/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373847 CMS
Regeneron Healthcare Solutions, Inc. $86.8904/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373849 CMS
Regeneron Healthcare Solutions, Inc. $76.9704/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373851 CMS
Regeneron Healthcare Solutions, Inc. $751.8404/10/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673373853 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $115,546.68 302
PY2020 $52,616.82 101
PY2021 $65,007.49 135
PY2022 $75,737.89 95
PY2023 $106,364.05 173
PY2024 $71,359.82 130
PY2025 $84,116.81 120

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $406,834.69 12
PY2024 Principal investigator $378,573.45 3
PY2023 Principal investigator $224,319.10 3
PY2022 Recipient $112.63 1
PY2022 Principal investigator $170,099.33 9
PY2021 Principal investigator $12,996.78 11
PY2020 Principal investigator $32,048.18 22
PY2019 Recipient $3,836.19 15
PY2019 Principal investigator $68,613.90 44

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $270,179.19 12/31/2025 Non-covered Recipient Entity
Pulmonary Health Physicians
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-PH due to Heart Failure with Preserved Ejection F No dispute reported 06/30/2026 1232938884
Principal investigator 1 United Therapeutics Corporation $9,757.70 10/08/2025 Non-covered Recipient Entity
St Joseph's Medical PC
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242388327
Principal investigator 1 United Therapeutics Corporation $1,966.90 09/11/2025 Non-covered Recipient Entity
St Joseph's Medical PC
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242388323
Principal investigator 1 United Therapeutics Corporation $2,314.00 05/27/2025 Non-covered Recipient Entity
St Joseph's Medical PC
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242388325
Principal investigator 1 United Therapeutics Corporation $10,573.60 05/27/2025 Non-covered Recipient Entity
St Joseph's Medical PC
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242388329
Principal investigator 1 United Therapeutics Corporation $43,040.40 05/27/2025 Non-covered Recipient Entity
St Joseph's Medical PC
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242388331
Principal investigator 1 United Therapeutics Corporation $1,966.90 05/07/2025 Non-covered Recipient Entity
St Joseph's Medical PC
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242388321
Principal investigator 1 United Therapeutics Corporation $1,157.00 04/09/2025 Non-covered Recipient Entity
St Joseph's Medical PC
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242388319
Principal investigator 1 Paratek Pharmaceuticals, Inc. $9,951.00 04/04/2025 Non-covered Recipient Entity
ST JOSEPHS MEDICAL PC
A Ph. 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, & Tolerability of Oral Omadacycline in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex No dispute reported 06/30/2026 1181711160
Principal investigator 1 United Therapeutics Corporation $2,314.00 02/26/2025 Non-covered Recipient Entity
St Joseph's Medical PC
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242388313
Principal investigator 1 United Therapeutics Corporation $10,573.60 02/12/2025 Non-covered Recipient Entity
St Joseph's Medical PC
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242388315
Principal investigator 1 United Therapeutics Corporation $43,040.40 02/12/2025 Non-covered Recipient Entity
St Joseph's Medical PC
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242388317